Rheumatology drug shortages
11 rheumatology medications are on the FDA shortage list right now. 2 have at least one manufacturer presentation listed Unavailable, 3 have Limited availability. Click a medication for its per-manufacturer, per-strength record and a change-only alert.
Adalimumab-adaz Injection
also: Hyrimoz
Not specified 5
Adalimumab-afzb Injection
also: Abrilada
Not specified 1
Adalimumab-ryvk Kit
also: Simlandi
Not specified 1
Allopurinol Tablet
also: Allopurinol
Not specified 4
Dexamethasone Sodium Phosphate Injection
also: Dexamethasone Sodium Phosphate
Limited 2Available 17
Diclofenac Sodium Tablet, Delayed Release
also: Diclofenac Sodium
Not specified 6
Hydroxychloroquine Sulfate Tablet
also: Hydroxychloroquine Sulfate
Not specified 1
Leflunomide Tablet
also: Arava
Not specified 5
Methotrexate Sodium Injection
also: Methotrexate
Unavailable 4Limited 3Available 7
Methylprednisolone Acetate Injection
also: Depo-Medrol, Methylprednisolone Acetate
Unavailable 7Limited 7Available 9
Triamcinolone Hexacetonide Injection
Available 1
This is the FDA's national supply record, not your pharmacy's shelf. A manufacturer listed "Available" can still be out of stock locally; ask your pharmacist. See what to do if your medication is in shortage.
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).